Issue published 30 December 2025 Abstract Background: To determine whether initiating a glucagon-like peptide-1 receptor agonist (GLP-1 RA) within 3 months of type 2 diabetes (T2DM) diagnosis alters the subsequent risk of overall and site-specific cancer and whether this association differs by baseline body-mass index (BMI)
Its also found in Wegovy , which is specifically approved for weight management
Experience the transformative power of Rosmar - Gluta Peeling Soap, expertly formulated to reveal flawless, luminous skin
Think of it as freeze-dried
Certain probiotic strains, particularly those from the Lactobacillus and Bifidobacterium families, have been studied for their potential to modulate gut hormone secretion
Monitor weight, labs, and symptoms regularly